Phase 0 Success Stories

SpectraCyte

Dr. Thomas Rich, right, and Dr. Silas Leavesley, left, are working to provide an advanced gastrointestinal endoscope for colorectal cancer detection through SpectraCyte. The Mobile-based startup won a $5,000 preliminary data grant from Alabama Launchpad.

Dr. Thomas Rich, right, and Dr. Silas Leavesley, left, are working to provide an advanced gastrointestinal endoscope for colorectal cancer detection through SpectraCyte. The Mobile-based startup won a $5,000 preliminary data grant from Alabama Launchpad.

 

The primary goal of SpectraCyte, a startup business located in Mobile and founded by a University of South Alabama-affiliated research team, is to provide a next-generation gastrointestinal endoscope that will allow improved sensitivity and specificity for early detection of colorectal cancers. SpectraCyte, co-founded by Dr.Silas Leavesley, assistant professor of chemical and biomolecular engineering, and Dr. Thomas Rich, associate professor of pharmacology, will also offer an imaging add-on for research microscopes that utilizes the same high-speed hyperspectral imaging technology.

“We were thrilled to hear about the Phase 0 awards available through Alabama Launchpad, which include both financial support for preliminary data as well as dedicated one-on-one time to work with a grants consultant while writing the grant,” Leavesley said. Leavesley noted that SpectraCyte will use the award to help collect preliminary data demonstrating the ability of the new endoscope to detect colorectal cancer and will also highly benefit from consultant feedback on its grant proposal.

Learn more about SpectraCyte by visiting our blog.